Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Goodwill & Intangibles (2019 - 2025)

X4 Pharmaceuticals filings provide 7 years of Goodwill & Intangibles readings, the most recent being $26.7 million for Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 2.56% to $26.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $26.7 million, a 2.56% decrease, with the full-year FY2025 number at $26.7 million, down 2.56% from a year prior.
  • Goodwill & Intangibles hit $26.7 million in Q4 2025 for X4 Pharmaceuticals, roughly flat from $26.8 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $27.8 million in Q2 2024 to a low of $17.4 million in Q4 2021.
  • Median Goodwill & Intangibles over the past 5 years was $22.0 million (2021), compared with a mean of $22.3 million.
  • Biggest five-year swings in Goodwill & Intangibles: crashed 36.0% in 2021 and later skyrocketed 59.94% in 2024.
  • X4 Pharmaceuticals' Goodwill & Intangibles stood at $17.4 million in 2021, then changed by 0.0% to $17.4 million in 2022, then changed by 0.0% to $17.4 million in 2023, then skyrocketed by 57.63% to $27.4 million in 2024, then fell by 2.56% to $26.7 million in 2025.
  • The last three reported values for Goodwill & Intangibles were $26.7 million (Q4 2025), $26.8 million (Q3 2025), and $27.0 million (Q2 2025) per Business Quant data.